Journavx: The Powerful New Oxycodone Alternative for Plastic Surgery Pain

A common question from patients preparing for any kind of surgery is, “what are my options if I want non-opioid pain medication after plastic surgery?” They worried about the side effects and addiction risks associated with oxycodone. For a long time, my honest answer was that our choices were limited. That is finally changing. I am excited to share the data and my experience with a newer medication on the scene, Journavx.

A recent paper, “Suzetrigine: What Should Plastic Surgeons Know?” was published in Plastic and Reconstructive Surgery Global Open in January 2026. It puts into writing something our practice has already been seeing firsthand with a medication called Journavx. We have been using it with our patients for nearly a year now. I’d like to walk you through what this medication is, why it matters, and what it could mean for your surgical journey.

To understand why this medication is such a big deal, it helps to understand how pain signals normally travel through your body.

Think about touching a hot stove. The moment your skin senses that heat, a signal fires along your nerves and travels up to your brain, which is what registers as “ouch, that hurts.” The signal moves as an electrical impulse, carried along your peripheral nerves through structures called voltage-gated sodium channels.

Journavx works right at that cellular level, in your peripheral nervous system, before the pain signal ever reaches your brain. It is highly selective for the specific channel involved in transmission of painful stimuli, which means it is doing a very targeted job rather than a broad one. This means it will not make you groggy like some other meds that affect your central and peripheral nervous system.

This is a fundamentally different approach than the pain medications most of us are familiar with. Narcotics like oxycodone work at the level of the brain itself. That is effective for severe pain, but it also comes with a long list of downsides:

• Drowsiness and that “loopy” or foggy feeling
• Nausea and vomiting, especially on an empty stomach
• Constipation
• Narcotic tolerance and physical dependency

The bottom line: Journavx blocks pain signals out at the nerve level, before they ever reach the brain. That targeted mechanism is exactly why patients are not reporting the sedation or GI side effects we typically see with narcotics.

I cannot tell you how many times a patient has told me they simply do not want to take their prescribed narcotic after surgery. They are either unhappy with how it makes them feel or they are worried about becoming addicted to it. Until recently, our alternatives for moderate to significant post-surgical pain were limited. Journavx changes that conversation.

The clinical research behind this medication is compelling. In the trials referenced in this new paper, patients taking Journavx experienced significantly less nausea and vomiting compared to those on narcotic pain medicine, and they did not report the same drowsy, ‘out of it’ feeling that often comes with oxycodone. Importantly, the pain relief itself held up well against narcotics in these comparisons, particularly following procedures like tummy tucks, which are known to be among the more uncomfortable recoveries we manage as plastic surgeons.

Here is some context that really puts this into perspective:

• Journavx is the first non narcotic pain medication to receive FDA approval in twenty years. Twenty years. That alone tells you how significant this moment is for pain management, not just in our specialty but in medicine as a whole.
• Pain relief held up well against narcotics, including in patients recovering from tummy tucks, one of the more uncomfortable recoveries we manage as plastic surgeons.
• Patients reported significantly less nausea and vomiting compared to those on narcotic pain medicine.
• No “loopy” or drowsy feeling that so often comes with oxycodone.

Over the past several months of incorporating Journavx into our post-operative protocols, our own patient experiences have echoed what the research shows. Patients are reporting good pain control without the grogginess and stomach upset that so often accompanies traditional narcotics. As more plastic surgeons read this paper, start asking questions, and look into using this medication with their own patients, I believe we are going to see it become a standard part of post-surgical pain management across our field.

If you have surgery on the horizon, whether with our practice or elsewhere, I encourage you to advocate for yourself. Ask your surgeon directly:

• Is Journavx an option for me?
• Would it be safe given the procedure I am having done?
• Is it something you would consider prescribing instead of, or alongside, a narcotic?

These are fair and important questions, and any surgeon who is staying current with the literature should be able to talk through it with you.

Remember: You are allowed to ask about your own pain management plan. If your surgeon has not brought up non-opioid options like Journavx, that conversation is worth starting yourself.

Pain management has not seen an innovation like this in two decades. As your surgeon, I want you to have every good option available to you. And right now, a non-opioid pain medication after plastic surgery like Journavx is one of the best ones we have seen in a long time.

Schedule a consultation with Dr. Tannan to discuss whether Journavx or another non-opioid approach is right for your procedure. (919) 797-0996.

Source: Wiegmann AL, Markewych AN, Cook JQ, Jejurikar S, Rohrich RJ. “Suzetrigine: What Should Plastic Surgeons Know?” Plastic and Reconstructive Surgery Global Open, January 16, 2026.